Search

The carbonyl cluster compound [GeRu6(CO)18HI] is unique in regard to its structure and bonding with a GeRu6 cluster core, a planar GeRu4HI unit, extensive multi‐center bonding, and an aromatic ring current similar to benzene (9‐10 nA T−1). The open‐shell cluster core is a Ge‐centered five‐membered Ru4(Ru2) ring with CO ligands and an additional H and I atom, each bridging two Ru atoms on opposite sides of the cluster core. The compound is prepared at 130 °C in a weakly‐coordinating ionic liquid. [ABSTRACT FROM AUTHOR]

The pseudo-ternary tin(II) halide [BMPyr]2[SnCl4] can be obtained just by mixing the starting materials [BMPyr]Cl and SnCl2 at room temperature without additional solvents. The compound shows bright Sn(II)-based emission of deep-red light (λmax: 740 nm) with a quantum yield of 88 ± 3% after optimised synthesis. Characterization is performed by X-ray structure analysis, infrared and fluorescence spectroscopy. Exemplary fluorescent thinfilms are realized by solvent processing. [ABSTRACT FROM AUTHOR]

The pseudo-ternary tin(II) halide [BMPyr]2[SnCl4] can be obtained just by mixing the starting materials [BMPyr]Cl and SnCl2 at room temperature without additional solvents. The compound shows bright Sn(II)-based emission of deep-red light (λmax: 740 nm) with a quantum yield of 88 ± 3% after optimised synthesis. Characterization is performed by X-ray structure analysis, infrared and fluorescence spectroscopy. Exemplary fluorescent thinfilms are realized by solvent processing. [ABSTRACT FROM AUTHOR]

Introduction: The WHO estimates that each year 5 million people are left permanently disabled after stroke. Adjuvant treatments to promote the effects of rehabilitation are urgently needed. Cortical excitability and neuroplasticity can be enhanced by non-invasive brain stimulation but evidence from sufficiently powered, randomized controlled multi-center clinical trials is absent. Methods: Neuroregeneration enhanced by transcranial direct current stimulation (tDCS) in stroke (NETS) tested efficacy and safety of anodal tDCS to the primary motor cortex of the lesioned hemisphere in the subacute phase (day 5–45) after cerebral ischemia. Stimulation was combined with standardized rehabilitative training and repeatedly applied in 10 sessions over a period of 2 weeks in a planned sample of 120 patients. Primary outcome parameter was upper-extremity function at the end of the 2-weeks intervention period of active treatment or placebo (1:1 randomization), measured by the upper-extremity Fugl-Meyer assessment. Sustainability of the treatment effect was evaluated by additional follow-up visits after 30 and 90 days. Further secondary endpoints included metrics of arm and hand function, stroke impact scale, and the depression module of the patient health questionnaire. Perspective: NETS was aimed at providing evidence for an effective and safe adjuvant treatment for patients after stroke. Trial registration: ClinicalTrials.gov Identifier NCT00909714. Registered May 28, 2009. [ABSTRACT FROM AUTHOR]

Introduction: The WHO estimates that each year 5 million people are left permanently disabled after stroke. Adjuvant treatments to promote the effects of rehabilitation are urgently needed. Cortical excitability and neuroplasticity can be enhanced by non-invasive brain stimulation but evidence from sufficiently powered, randomized controlled multi-center clinical trials is absent. Methods: Neuroregeneration enhanced by transcranial direct current stimulation (tDCS) in stroke (NETS) tested efficacy and safety of anodal tDCS to the primary motor cortex of the lesioned hemisphere in the subacute phase (day 5–45) after cerebral ischemia. Stimulation was combined with standardized rehabilitative training and repeatedly applied in 10 sessions over a period of 2 weeks in a planned sample of 120 patients. Primary outcome parameter was upper-extremity function at the end of the 2-weeks intervention period of active treatment or placebo (1:1 randomization), measured by the upper-extremity Fugl-Meyer assessment. Sustainability of the treatment effect was evaluated by additional follow-up visits after 30 and 90 days. Further secondary endpoints included metrics of arm and hand function, stroke impact scale, and the depression module of the patient health questionnaire. Perspective: NETS was aimed at providing evidence for an effective and safe adjuvant treatment for patients after stroke. Trial registration: ClinicalTrials.gov Identifier NCT00909714. Registered May 28, 2009. [ABSTRACT FROM AUTHOR]

The halogenido stannates(II) [BMIm][Sn3Cl7] and [BMIm][Sn4Br9] are obtained by ionic‐liquid‐based synthesis with SnX2 and [BMIm]X (X=Cl, Br; [BMIm]=1‐butyl‐3‐methylimidazolium) near room temperature (45–50 °C). Both form colorless, moisture‐sensitive crystals and exhibit layered anionic networks. [BMIm][Sn3Cl7] contains "horseshoe"‐like ∞1(SnCl1/1Cl2/2) chains that are linked via [SnCl3]− anions to ∞2[Sn3Cl7]− zigzag‐planes. [BMIm][Sn4Br9] contains a complex ∞2[Sn4Br9]− network with altogether four different crystallographic Sn2+ sites and different coordination. For comparison with these complex halogenido stannates(II), PbCl2/PbBr2 are reacted with similar conditions, which, however, only results in [BMIm][PbCl3] containing ∞1[PbCl3]− chains. Beside the crystal structures, the thermal and optical properties are examined and feature certain emission of visible light for all title compounds at room temperature. Whereas the quantum yields of [BMIm][Sn4Br9] (3 %) and [BMIm][PbCl3] (21 %) are low, [BMIm][Sn3Cl7] shows surprisingly efficient photoluminescence with a quantum yield of 46 %. [ABSTRACT FROM AUTHOR]

[BMIm][Sn(AlCl4)3] (1) ([BMIm]: 1-butyl-3-methylimidazolium), [BMPyr][Sn(AlCl4)3] (2) ([BMPyr]: 1-butyl-1-methyl-pyrrolidinium), and [BMIm][Pb(AlCl4)3] (3) are obtained by reaction of SnCl2/PbCl2 in [BMIm]Cl/[BMPyr]Cl/AlCl3-based ionic liquids. The colourless crystals of the title compounds contain infinite 1∞ [M(AlCl4)3]n− chains (M: Sn, Pb) that are separated by the voluminous [BMIm]+/[BMPyr]+ cations. The central Sn2+/Pb2+ is coordinated by chlorine in the form of distorted squared anti-prismatic polyhedra. Each Cl atom, in turn, is part of an [AlCl4]− tetrahedron that interlinks Sn2+/Pb2+ to the chain-like building unit. In addition to the novel structural arrangement, all title compounds surprisingly show intense white-light emission. Although Sn2+ and Pb2+ are well-known as dopants in conventional phosphors, efficient luminescence via s–p-transitions of compounds containing Sn2+/Pb2+ in molar quantities and as regular lattice constituents is rare. The emission of [BMIm][Sn(AlCl4)3] and [BMPyr][Sn(AlCl4)3] is very efficient with quantum yields of 51 and 76%, which belong to the highest values known for s–p-based luminescence of Sn2+. [ABSTRACT FROM AUTHOR]

[BMIm][Sn(AlCl4)3] (1) ([BMIm]: 1-butyl-3-methylimidazolium), [BMPyr][Sn(AlCl4)3] (2) ([BMPyr]: 1-butyl-1-methyl-pyrrolidinium), and [BMIm][Pb(AlCl4)3] (3) are obtained by reaction of SnCl2/PbCl2 in [BMIm]Cl/[BMPyr]Cl/AlCl3-based ionic liquids. The colourless crystals of the title compounds contain infinite 1∞ [M(AlCl4)3]n− chains (M: Sn, Pb) that are separated by the voluminous [BMIm]+/[BMPyr]+ cations. The central Sn2+/Pb2+ is coordinated by chlorine in the form of distorted squared anti-prismatic polyhedra. Each Cl atom, in turn, is part of an [AlCl4]− tetrahedron that interlinks Sn2+/Pb2+ to the chain-like building unit. In addition to the novel structural arrangement, all title compounds surprisingly show intense white-light emission. Although Sn2+ and Pb2+ are well-known as dopants in conventional phosphors, efficient luminescence via s–p-transitions of compounds containing Sn2+/Pb2+ in molar quantities and as regular lattice constituents is rare. The emission of [BMIm][Sn(AlCl4)3] and [BMPyr][Sn(AlCl4)3] is very efficient with quantum yields of 51 and 76%, which belong to the highest values known for s–p-based luminescence of Sn2+. [ABSTRACT FROM AUTHOR]

Nine Ge−Fe carbonyl cluster compounds are prepared via ionic liquids‐based synthesis. This includes the novel compounds [EMIm][Fe(CO)3I(GeI3)], [EHIm][Fe(CO)3I(GeI3)], [BMIm][GeI2{Fe(CO)4}2(μ‐I)][AlCl4]2, [GeI2{Fe(CO)4}2(μ‐I)][Fe(AlBr4)3], [BMIm]2[(FeI2)0.75{Fe(CO)2I(GeI3)2}2], and [EHIm][Fe(CO)4(GeI2)2Fe(CO)3GeI3] as well as the previously reported compounds (Fe(CO)4(GeI3)2, FeI4{GeI3Fe(CO)3}2, and Ge12{Fe(CO)3}8(μ‐I)4 (EMIm: 1‐ethyl‐3‐methylimidazolium, EHIm: 1‐ethylimidazolium, BMIm: 1‐butyl‐3‐methylimidazolium). With this series of compounds, a comparison of synthesis conditions and structural features is possible and, for instance, allows correlating the composition and structure of the respective Ge−Fe carbonyl cluster compounds with the type and acidity of the ionic liquid. With [EMIm][{GeI3}2Fe(CO)3I], moreover, we can exemplarily show the thermal decomposition as a single‐source precursor in the ionic liquid, resulting in bimetallic Ge−Fe nanoparticles with small size and narrow size distribution (7.0±1.4 nm). [ABSTRACT FROM AUTHOR]

[SnI8{Fe(CO)4}4][Al2Cl7]2 contains the [SnI8{Fe(CO)4}4]2+ cation with an unprecedented highly coordinated, bicapped SnI8 prism. Given the eightfold coordination with the most voluminous stable halide, it is all the more surprising that this SnI8 arrangement is surrounded only by fragile Fe(CO)4 groups in a clip‐like fashion. Inspite of a predominantly ionic bonding situation in [SnI8{Fe(CO)4}4]2+, the I−⋅⋅⋅I− distances are considerably shortened (down to 371 pm) and significantly less than the van der Waals distance (420 pm). The title compound is characterized by single‐crystal structure analysis, spectroscopic methods (EDXS, FTIR, Raman, UV/Vis, Mössbauer), thermogravimetry, and density functional theory methods. [ABSTRACT FROM AUTHOR]

[SnI8{Fe(CO)4}4][Al2Cl7]2 enthält ein [SnI8{Fe(CO)4}4]2+‐Kation mit einem beispiellos hochkoordinierten, zweifach überdachten SnI8‐Prisma. In Anbetracht der achtfachen Koordination mit dem voluminösesten, stabilen Halogenid ist es umso erstaunlicher, dass die SnI8‐Baugruppe nur von fragilen Fe(CO)4‐Gruppen klammerartig umgeben ist. Trotz der überwiegend ionischen Bindungssituation in [SnI8{Fe(CO)4}4]2+ sind die I−⋅⋅⋅I−‐Abstände verkleinert (bis zu 371 pm) und liegen deutlich unter dem Van‐der‐Waals‐Abstand (420 pm). Charakterisiert wurde die Titelverbindung durch Einkristallstrukturanalyse, spektroskopische Methoden (EDXS, FT‐IR, Raman, UV/Vis, Mößbauer), Thermogravimetrie und Dichtefunktionaltheorie. [ABSTRACT FROM AUTHOR]